EverSource Wealth Advisors’s ProKidney PROK Stock Holding History
Bought
Maintained
Sold
Other funds holding PROK
EverSource Wealth Advisors's PROK Position: Q3 2026 in Review
EverSource Wealth Advisors opened a new position in ProKidney (PROK) in Q3 2026: 82 shares worth $136. The stake represents ﹤0.01% of the portfolio and ranks #4365 among its holdings. This is a return to the name: EverSource Wealth Advisors previously reported a position in PROK as recently as Q3 2025.
EverSource Wealth Advisors first reported a position in PROK in Q4 2024 and has held it in 5 quarters since. The position peaked at $602 in Q2 2025. 67 funds tracked by Wall St. Rank hold PROK as of Q3 2026.
- EverSource Wealth Advisors held 82 shares of ProKidney worth $136 as of Q3 2026.
- ProKidney was a new EverSource Wealth Advisors position in Q3 2026.
- ProKidney made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4365 holding.
- EverSource Wealth Advisors first reported a position in ProKidney in Q4 2024 and has held it in 5 quarters since.
- EverSource Wealth Advisors's ProKidney position peaked at $602 in Q2 2025.
- 67 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.
Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.